Loading…

Quality of Life in Glaucoma: A Review of the Literature

The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blindin...

Full description

Saved in:
Bibliographic Details
Published in:Advances in therapy 2016-06, Vol.33 (6), p.959-981
Main Authors: Quaranta, Luciano, Riva, Ivano, Gerardi, Chiara, Oddone, Francesco, Floriano, Irene, Konstas, Anastasios G. P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3
cites cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3
container_end_page 981
container_issue 6
container_start_page 959
container_title Advances in therapy
container_volume 33
creator Quaranta, Luciano
Riva, Ivano
Gerardi, Chiara
Oddone, Francesco
Floriano, Irene
Konstas, Anastasios G. P.
description The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.
doi_str_mv 10.1007/s12325-016-0333-6
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4920851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1799559639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk4_gBfp0Us1L2mT1IMwhk5hIIqCt5Blr1tH186knezbm9EpevHwyOH_e_8XfoScA70CSuW1B8ZZGlMQMeWcx-KA9EGJNA7DDkmfygRixtV7j5x4v6SUUZmqY9JjErgSNOkT-dyasmi2UZ1HkyLHqKiicWlaW6_MTTSMXnBT4OcubRYYiAadaVqHp-QoN6XHs_07IG_3d6-jh3jyNH4cDSexTalq4lnOE2oQULFshrmiyCBJcgBhrRVAwUpI5JRLI3iSTmcqV5hxNEnGmLLc8gG57XrX7XSFM4tV40yp165YGbfVtSn036QqFnpeb3RooCqFUHC5L3D1R4u-0avCWyxLU2Hdeg0yy9I0EzwLKHSodbX3DvOfM0D1TrjuhOsgXO-EaxF2Ln7_72fj23AAWAf4EFVzdHpZt64Kzv5p_QIpD4q9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799559639</pqid></control><display><type>article</type><title>Quality of Life in Glaucoma: A Review of the Literature</title><source>Springer Link</source><creator>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</creator><creatorcontrib>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</creatorcontrib><description>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</description><identifier>ISSN: 0741-238X</identifier><identifier>EISSN: 1865-8652</identifier><identifier>DOI: 10.1007/s12325-016-0333-6</identifier><identifier>PMID: 27138604</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Disease Management ; Endocrinology ; Glaucoma - diagnosis ; Glaucoma - psychology ; Glaucoma - therapy ; Health technology assessment ; Humans ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Oncology ; Patient Care Planning ; Pharmacology/Toxicology ; Prognosis ; Quality of Life ; Review ; Rheumatology ; Visual Field Tests</subject><ispartof>Advances in therapy, 2016-06, Vol.33 (6), p.959-981</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</citedby><cites>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27138604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quaranta, Luciano</creatorcontrib><creatorcontrib>Riva, Ivano</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Oddone, Francesco</creatorcontrib><creatorcontrib>Floriano, Irene</creatorcontrib><creatorcontrib>Konstas, Anastasios G. P.</creatorcontrib><title>Quality of Life in Glaucoma: A Review of the Literature</title><title>Advances in therapy</title><addtitle>Adv Ther</addtitle><addtitle>Adv Ther</addtitle><description>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</description><subject>Cardiology</subject><subject>Disease Management</subject><subject>Endocrinology</subject><subject>Glaucoma - diagnosis</subject><subject>Glaucoma - psychology</subject><subject>Glaucoma - therapy</subject><subject>Health technology assessment</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Patient Care Planning</subject><subject>Pharmacology/Toxicology</subject><subject>Prognosis</subject><subject>Quality of Life</subject><subject>Review</subject><subject>Rheumatology</subject><subject>Visual Field Tests</subject><issn>0741-238X</issn><issn>1865-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAUx4Mobk4_gBfp0Us1L2mT1IMwhk5hIIqCt5Blr1tH186knezbm9EpevHwyOH_e_8XfoScA70CSuW1B8ZZGlMQMeWcx-KA9EGJNA7DDkmfygRixtV7j5x4v6SUUZmqY9JjErgSNOkT-dyasmi2UZ1HkyLHqKiicWlaW6_MTTSMXnBT4OcubRYYiAadaVqHp-QoN6XHs_07IG_3d6-jh3jyNH4cDSexTalq4lnOE2oQULFshrmiyCBJcgBhrRVAwUpI5JRLI3iSTmcqV5hxNEnGmLLc8gG57XrX7XSFM4tV40yp165YGbfVtSn036QqFnpeb3RooCqFUHC5L3D1R4u-0avCWyxLU2Hdeg0yy9I0EzwLKHSodbX3DvOfM0D1TrjuhOsgXO-EaxF2Ln7_72fj23AAWAf4EFVzdHpZt64Kzv5p_QIpD4q9</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Quaranta, Luciano</creator><creator>Riva, Ivano</creator><creator>Gerardi, Chiara</creator><creator>Oddone, Francesco</creator><creator>Floriano, Irene</creator><creator>Konstas, Anastasios G. P.</creator><general>Springer Healthcare</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160601</creationdate><title>Quality of Life in Glaucoma: A Review of the Literature</title><author>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiology</topic><topic>Disease Management</topic><topic>Endocrinology</topic><topic>Glaucoma - diagnosis</topic><topic>Glaucoma - psychology</topic><topic>Glaucoma - therapy</topic><topic>Health technology assessment</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Patient Care Planning</topic><topic>Pharmacology/Toxicology</topic><topic>Prognosis</topic><topic>Quality of Life</topic><topic>Review</topic><topic>Rheumatology</topic><topic>Visual Field Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quaranta, Luciano</creatorcontrib><creatorcontrib>Riva, Ivano</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Oddone, Francesco</creatorcontrib><creatorcontrib>Floriano, Irene</creatorcontrib><creatorcontrib>Konstas, Anastasios G. P.</creatorcontrib><collection>Springer_OA刊</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advances in therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quaranta, Luciano</au><au>Riva, Ivano</au><au>Gerardi, Chiara</au><au>Oddone, Francesco</au><au>Floriano, Irene</au><au>Konstas, Anastasios G. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quality of Life in Glaucoma: A Review of the Literature</atitle><jtitle>Advances in therapy</jtitle><stitle>Adv Ther</stitle><addtitle>Adv Ther</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>33</volume><issue>6</issue><spage>959</spage><epage>981</epage><pages>959-981</pages><issn>0741-238X</issn><eissn>1865-8652</eissn><abstract>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>27138604</pmid><doi>10.1007/s12325-016-0333-6</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-238X
ispartof Advances in therapy, 2016-06, Vol.33 (6), p.959-981
issn 0741-238X
1865-8652
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4920851
source Springer Link
subjects Cardiology
Disease Management
Endocrinology
Glaucoma - diagnosis
Glaucoma - psychology
Glaucoma - therapy
Health technology assessment
Humans
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Patient Care Planning
Pharmacology/Toxicology
Prognosis
Quality of Life
Review
Rheumatology
Visual Field Tests
title Quality of Life in Glaucoma: A Review of the Literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quality%20of%20Life%20in%20Glaucoma:%20A%20Review%20of%20the%20Literature&rft.jtitle=Advances%20in%20therapy&rft.au=Quaranta,%20Luciano&rft.date=2016-06-01&rft.volume=33&rft.issue=6&rft.spage=959&rft.epage=981&rft.pages=959-981&rft.issn=0741-238X&rft.eissn=1865-8652&rft_id=info:doi/10.1007/s12325-016-0333-6&rft_dat=%3Cproquest_pubme%3E1799559639%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1799559639&rft_id=info:pmid/27138604&rfr_iscdi=true